|
Volumn 141, Issue 6, 2005, Pages 794-795
|
Chronic cutaneous fusariosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
VORICONAZOLE;
ADULT;
ANAMNESIS;
ATYPICAL MYCOBACTERIOSIS;
BACTERIAL INFECTION;
CASE REPORT;
CHRONIC DISEASE;
CUTANEOUS FUSARIOSIS;
DEBRIDEMENT;
DERMATOMYCOSIS;
DIFFERENTIAL DIAGNOSIS;
ERYTHEMA;
FUNGAL CELL CULTURE;
FUSARIUM SOLANI;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LABORATORY TEST;
MALE;
NOTE;
PRIORITY JOURNAL;
PRURITUS;
SKIN BIOPSY;
SKIN INFLAMMATION;
SPIDER BITE;
FOLLOW UP;
FUSARIUM;
HODGKIN DISEASE;
HOSPITALIZATION;
IMMUNE DEFICIENCY;
IMMUNOHISTOCHEMISTRY;
IMMUNOLOGY;
ISOLATION AND PURIFICATION;
LETTER;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
NEEDLE BIOPSY;
RISK ASSESSMENT;
TREATMENT OUTCOME;
ADULT;
AMPHOTERICIN B;
BIOPSY, NEEDLE;
CHRONIC DISEASE;
COMBINED MODALITY THERAPY;
DEBRIDEMENT;
DERMATOMYCOSES;
FOLLOW-UP STUDIES;
FUSARIUM;
HODGKIN DISEASE;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOHISTOCHEMISTRY;
MALE;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 21844456902
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: 10.1001/archderm.141.6.794 Document Type: Note |
Times cited : (12)
|
References (5)
|